Cargando…

Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson’s Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage

Trefoil factor 3 (TFF3), cholinesterase activity (ChE activity) and homocysteine (Hcy) play critical roles in modulating recognition, learning and memory in neurodegenerative diseases, such as Parkinson’s disease dementia (PDD) and vascular parkinsonism with dementia (VPD). However, whether they can...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Jing, Chen, Zhigang, Liang, Caiqian, Fu, Yongmei, Wei, Xiaobo, Lu, Jianjun, Pan, Mengqiu, Guo, Yue, Liao, Xinxue, Xie, Huifang, Wu, Duobin, Li, Min, Liang, Lihui, Wang, Penghua, Wang, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JKL International LLC 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772858/
https://www.ncbi.nlm.nih.gov/pubmed/29392081
http://dx.doi.org/10.14336/AD.2017.0416
_version_ 1783293473812643840
author Zou, Jing
Chen, Zhigang
Liang, Caiqian
Fu, Yongmei
Wei, Xiaobo
Lu, Jianjun
Pan, Mengqiu
Guo, Yue
Liao, Xinxue
Xie, Huifang
Wu, Duobin
Li, Min
Liang, Lihui
Wang, Penghua
Wang, Qing
author_facet Zou, Jing
Chen, Zhigang
Liang, Caiqian
Fu, Yongmei
Wei, Xiaobo
Lu, Jianjun
Pan, Mengqiu
Guo, Yue
Liao, Xinxue
Xie, Huifang
Wu, Duobin
Li, Min
Liang, Lihui
Wang, Penghua
Wang, Qing
author_sort Zou, Jing
collection PubMed
description Trefoil factor 3 (TFF3), cholinesterase activity (ChE activity) and homocysteine (Hcy) play critical roles in modulating recognition, learning and memory in neurodegenerative diseases, such as Parkinson’s disease dementia (PDD) and vascular parkinsonism with dementia (VPD). However, whether they can be used as reliable predictors to evaluate the severity and progression of PDD and VPD remains largely unknown. Methods: We performed a cross-sectional study that included 92 patients with PDD, 82 patients with VPD and 80 healthy controls. Serum levels of TFF3, ChE activity and Hcy were measured. Several scales were used to rate the severity of PDD and VPD. Receivers operating characteristic (ROC) curves were applied to map the diagnostic accuracy of PDD and VPD patients compared to healthy subjects. Results: Compared with healthy subjects, the serum levels of TFF3 and ChE activity were lower, while Hcy was higher in the PDD and VPD patients. These findings were especially prominent in male patients. The three biomarkers displayed differences between PDD and VPD sub-groups based on genders and UPDRS (III) scores’ distribution. Interestingly, these increased serum Hcy levels were significantly and inversely correlated with decreased TFF3/ChE activity levels. There were significant correlations between TFF3/ChE activity/Hcy levels and PDD/VPD severities, including motor dysfunction, declining cognition and mood/gastrointestinal symptoms. Additionally, ROC curves for the combination of TFF3, ChE activity and Hcy showed potential diagnostic value in discriminating PDD and VPD patients from healthy controls. Conclusions: Our findings suggest that serum TFF3, ChE activity and Hcy levels may underlie the pathophysiological mechanisms of PDD and VPD. As the race to find biomarkers or predictors for these diseases intensifies, a better understanding of the roles of TFF3, ChE activity and Hcy may yield insights into the pathogenesis of PDD and VPD.
format Online
Article
Text
id pubmed-5772858
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher JKL International LLC
record_format MEDLINE/PubMed
spelling pubmed-57728582018-02-02 Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson’s Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage Zou, Jing Chen, Zhigang Liang, Caiqian Fu, Yongmei Wei, Xiaobo Lu, Jianjun Pan, Mengqiu Guo, Yue Liao, Xinxue Xie, Huifang Wu, Duobin Li, Min Liang, Lihui Wang, Penghua Wang, Qing Aging Dis Orginal Article Trefoil factor 3 (TFF3), cholinesterase activity (ChE activity) and homocysteine (Hcy) play critical roles in modulating recognition, learning and memory in neurodegenerative diseases, such as Parkinson’s disease dementia (PDD) and vascular parkinsonism with dementia (VPD). However, whether they can be used as reliable predictors to evaluate the severity and progression of PDD and VPD remains largely unknown. Methods: We performed a cross-sectional study that included 92 patients with PDD, 82 patients with VPD and 80 healthy controls. Serum levels of TFF3, ChE activity and Hcy were measured. Several scales were used to rate the severity of PDD and VPD. Receivers operating characteristic (ROC) curves were applied to map the diagnostic accuracy of PDD and VPD patients compared to healthy subjects. Results: Compared with healthy subjects, the serum levels of TFF3 and ChE activity were lower, while Hcy was higher in the PDD and VPD patients. These findings were especially prominent in male patients. The three biomarkers displayed differences between PDD and VPD sub-groups based on genders and UPDRS (III) scores’ distribution. Interestingly, these increased serum Hcy levels were significantly and inversely correlated with decreased TFF3/ChE activity levels. There were significant correlations between TFF3/ChE activity/Hcy levels and PDD/VPD severities, including motor dysfunction, declining cognition and mood/gastrointestinal symptoms. Additionally, ROC curves for the combination of TFF3, ChE activity and Hcy showed potential diagnostic value in discriminating PDD and VPD patients from healthy controls. Conclusions: Our findings suggest that serum TFF3, ChE activity and Hcy levels may underlie the pathophysiological mechanisms of PDD and VPD. As the race to find biomarkers or predictors for these diseases intensifies, a better understanding of the roles of TFF3, ChE activity and Hcy may yield insights into the pathogenesis of PDD and VPD. JKL International LLC 2018-02-01 /pmc/articles/PMC5772858/ /pubmed/29392081 http://dx.doi.org/10.14336/AD.2017.0416 Text en Copyright: © 2017 Zhou et al. http://creativecommons.org/licenses/by/2.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle Orginal Article
Zou, Jing
Chen, Zhigang
Liang, Caiqian
Fu, Yongmei
Wei, Xiaobo
Lu, Jianjun
Pan, Mengqiu
Guo, Yue
Liao, Xinxue
Xie, Huifang
Wu, Duobin
Li, Min
Liang, Lihui
Wang, Penghua
Wang, Qing
Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson’s Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage
title Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson’s Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage
title_full Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson’s Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage
title_fullStr Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson’s Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage
title_full_unstemmed Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson’s Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage
title_short Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson’s Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage
title_sort trefoil factor 3, cholinesterase and homocysteine: potential predictors for parkinson’s disease dementia and vascular parkinsonism dementia in advanced stage
topic Orginal Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772858/
https://www.ncbi.nlm.nih.gov/pubmed/29392081
http://dx.doi.org/10.14336/AD.2017.0416
work_keys_str_mv AT zoujing trefoilfactor3cholinesteraseandhomocysteinepotentialpredictorsforparkinsonsdiseasedementiaandvascularparkinsonismdementiainadvancedstage
AT chenzhigang trefoilfactor3cholinesteraseandhomocysteinepotentialpredictorsforparkinsonsdiseasedementiaandvascularparkinsonismdementiainadvancedstage
AT liangcaiqian trefoilfactor3cholinesteraseandhomocysteinepotentialpredictorsforparkinsonsdiseasedementiaandvascularparkinsonismdementiainadvancedstage
AT fuyongmei trefoilfactor3cholinesteraseandhomocysteinepotentialpredictorsforparkinsonsdiseasedementiaandvascularparkinsonismdementiainadvancedstage
AT weixiaobo trefoilfactor3cholinesteraseandhomocysteinepotentialpredictorsforparkinsonsdiseasedementiaandvascularparkinsonismdementiainadvancedstage
AT lujianjun trefoilfactor3cholinesteraseandhomocysteinepotentialpredictorsforparkinsonsdiseasedementiaandvascularparkinsonismdementiainadvancedstage
AT panmengqiu trefoilfactor3cholinesteraseandhomocysteinepotentialpredictorsforparkinsonsdiseasedementiaandvascularparkinsonismdementiainadvancedstage
AT guoyue trefoilfactor3cholinesteraseandhomocysteinepotentialpredictorsforparkinsonsdiseasedementiaandvascularparkinsonismdementiainadvancedstage
AT liaoxinxue trefoilfactor3cholinesteraseandhomocysteinepotentialpredictorsforparkinsonsdiseasedementiaandvascularparkinsonismdementiainadvancedstage
AT xiehuifang trefoilfactor3cholinesteraseandhomocysteinepotentialpredictorsforparkinsonsdiseasedementiaandvascularparkinsonismdementiainadvancedstage
AT wuduobin trefoilfactor3cholinesteraseandhomocysteinepotentialpredictorsforparkinsonsdiseasedementiaandvascularparkinsonismdementiainadvancedstage
AT limin trefoilfactor3cholinesteraseandhomocysteinepotentialpredictorsforparkinsonsdiseasedementiaandvascularparkinsonismdementiainadvancedstage
AT lianglihui trefoilfactor3cholinesteraseandhomocysteinepotentialpredictorsforparkinsonsdiseasedementiaandvascularparkinsonismdementiainadvancedstage
AT wangpenghua trefoilfactor3cholinesteraseandhomocysteinepotentialpredictorsforparkinsonsdiseasedementiaandvascularparkinsonismdementiainadvancedstage
AT wangqing trefoilfactor3cholinesteraseandhomocysteinepotentialpredictorsforparkinsonsdiseasedementiaandvascularparkinsonismdementiainadvancedstage